Russia tightens restrictions on exporting cash rubles to Uzbekistan and other countries
Read more
Sputnik Uzbekistan
sputniknews.uz

Russia tightens restrictions on exporting cash rubles to Uzbekistan and other countries

Russia has tightened the rules for taking out cash rubles to Uzbekistan and several other states. A limit of 1 million rubles is now set for individuals.

According to the new procedure, individuals are prohibited from leaving Russia with cash rubles in these countries in an amount exceeding 1 million rubles. However, there are exceptions for taking out larger sums. For this, the money must be taken out through border points of international airports established by the Russian government, and bank documents confirming that the entire amount was withdrawn from a bank account or deposit must be provided.

The requirements for legal entities and individual entrepreneurs are stricter: they are prohibited from taking out cash rubles regardless of the amount. Nevertheless, certain exceptions are also provided for them, as specified in the decree.

In case of violation of the rules, part of the amount exceeding 1 million rubles will be confiscated from the individual, and the entire amount being taken out will be confiscated from the legal entity or individual entrepreneur.

Previously, the restriction for individuals concerned amounts above the equivalent of 100 thousand dollars and applied only to EOII countries. Now the limit has been reduced to 1 million rubles, and Uzbekistan, Tajikistan, and Azerbaijan have been included in the list. This decree came into force on the date of its signing.

Similar stories

Sun Pharma plans to sell local debt worth $1 billion to repay loan
Read more
business-standard.com

Sun Pharma plans to sell local debt worth $1 billion to repay loan

The Indian company Sun Pharmaceutical Industries intends to raise approximately 100 billion rupees, equivalent to about $1.04 billion, through the sale of rupee-denominated debt obligations. These funds are intended to partially finance a bridge loan obtained for the acquisition of the American healthcare company Organon & Co., three sources reported on Tuesday.

Bridge loans are typically short-term borrowings taken before takeover deals to provide financing for the transaction. Later, this loan may be replaced by more permanent financing through bonds or other loans.

The country's largest pharmaceutical manufacturer by market capitalization previously closed a bridge loan syndication worth nearly $12 billion with an 18-month maturity to acquire Organon. The State Bank of India, the country's largest lender by assets, was also part of this syndicate, sources clarified.

Sources requested anonymity as they are not authorized to speak to the media. Sun Pharma did not immediately respond to Reuters' request for comment.

Banks expect that the total volume of domestic corporate debt issuances this year will reach record levels, as higher rates in the US make dollar financing more expensive, forcing companies to seek domestic funding opportunities, one source noted.

Sun Pharma plans to sell shorter-term bonds with maturities of two, three, and four years. This move comes amid attempts by Indian companies to lock in borrowing costs before a potential interest rate hike by the Reserve Bank of India. A rupee debt issuance worth about $3 billion is scheduled in the coming days.

Popular